CCNK, cyclin K, 8812

N. diseases: 22; N. variants: 0
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES
0.300 GeneticVariation disease UNIPROT De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism. 30122539 2018
CUI: C0016202
Disease: Flatfoot
Flatfoot
0.100 Biomarker phenotype HPO
CUI: C0020534
Disease: Orbital separation excessive
Orbital separation excessive
0.100 Biomarker phenotype HPO
CUI: C0221355
Disease: Macrocephaly
Macrocephaly
0.100 Biomarker disease HPO
CUI: C0239234
Disease: Low set ears
Low set ears
0.100 Biomarker disease HPO
CUI: C0426429
Disease: Broad nasal tip
Broad nasal tip
0.100 Biomarker phenotype HPO
CUI: C0426886
Disease: Tapering fingers (finding)
Tapering fingers (finding)
0.100 Biomarker phenotype HPO
CUI: C0431478
Disease: Posteriorly rotated ear
Posteriorly rotated ear
0.100 Biomarker disease HPO
CUI: C0557874
Disease: Global developmental delay
Global developmental delay
0.100 Biomarker disease HPO
CUI: C1844809
Disease: Thick nasal alae
Thick nasal alae
0.100 Biomarker phenotype HPO
CUI: C1849340
Disease: Long palpebral fissure
Long palpebral fissure
0.100 Biomarker phenotype HPO
CUI: C1849367
Disease: Nasal bridge wide
Nasal bridge wide
0.100 Biomarker phenotype HPO
CUI: C1865014
Disease: Long philtrum
Long philtrum
0.100 Biomarker phenotype HPO
CUI: C3276036
Disease: High anterior hairline
High anterior hairline
0.100 Biomarker phenotype HPO
CUI: C4021066
Disease: Narrow jaw
Narrow jaw
0.100 Biomarker phenotype HPO
CUI: C4281771
Disease: Thin eyebrow
Thin eyebrow
0.100 Biomarker phenotype HPO
CUI: C0266617
Disease: Congenital anomaly of face
Congenital anomaly of face
0.010 GeneticVariation group BEFREE De Novo Mutations of CCNK Cause a Syndromic Neurodevelopmental Disorder with Distinctive Facial Dysmorphism. 30122539 2018
CUI: C0596263
Disease: Carcinogenesis
Carcinogenesis
0.010 Biomarker phenotype BEFREE We discuss the implications of our findings in light of recent reports linking cyclin K and CDK12 to human tumorigenesis. 29760377 2018
CUI: C1535926
Disease: Neurodevelopmental Disorders
Neurodevelopmental Disorders
0.010 GeneticVariation group BEFREE These defects were partially rescued by wild-type mRNA coding CCNK but not the mRNA with the identified likely pathogenic variant c.331A>G, supporting a causal role of CCNK variants in neurodevelopmental disorders. 30122539 2018
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate
0.010 Biomarker disease BEFREE Moreover, our results indicate that Cyclin K is a putative predictive biomarker for clinical outcome and therapy response for patients with prostate cancer. 28670704 2017
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma
0.010 Biomarker disease BEFREE Moreover, our results indicate that Cyclin K is a putative predictive biomarker for clinical outcome and therapy response for patients with prostate cancer. 28670704 2017
CUI: C0153594
Disease: Malignant neoplasm of testis
Malignant neoplasm of testis
0.010 AlteredExpression disease BEFREE In addition, we found that cyclin K is highly expressed in human testicular cancers. 25004108 2014